Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PRL as a novel potent cofactor for platelet aggregation.

H Wallaschofski1, M Donné, M Eigenthaler

  • 1Department of Internal Medicine III, University of Leipzig, Germany.

The Journal of Clinical Endocrinology and Metabolism
|December 12, 2001
PubMed
Summary

Elevated prolactin (PRL) levels in pregnancy increase platelet activation and aggregation, potentially explaining the higher risk of venous thromboembolism (VTE) during this period.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Live-cell imaging reveals decreased cAMP in a PFE-associated c.1050-3C>G PTH1R cell model.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Ongoing outbreak of maternal parvovirus B19 infections in Germany since end of 2023: consequence of COVID-19 pandemic?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Video of the Month: Pulsating Umbilicus in a Neonate with Left Ventricular Diverticulum.

European journal of pediatric surgery reports·2024
Same author

Evaluation of treatment with human chorionic gonadotropin at transfer of in vitro-produced beef embryos on reproductive outcomes in lactating multiparous Jersey cows after a synchronized ovulation.

Journal of dairy science·2024
Same author

Retinocytoma Undergoing Retinoblastoma Transformation in an Adult Patient.

Case reports in ophthalmological medicine·2023
Same author

Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022

Area of Science:

  • Reproductive Endocrinology
  • Hematology
  • Thrombosis Research

Background:

  • Pregnancy is a state of hypercoagulability, increasing venous thromboembolism (VTE) risk.
  • The underlying mechanisms for elevated VTE risk during pregnancy and postpartum remain unclear.
  • Prolactin (PRL), a hormone significantly increased during pregnancy and lactation, is investigated for its role in platelet activation.

Purpose of the Study:

  • To investigate potential platelet functional abnormalities associated with elevated prolactin (PRL) levels in pregnancy.
  • To determine if human PRL influences platelet aggregation and P-selectin expression.
  • To explore the link between hyperprolactinemia and the increased risk of VTE in pregnant women.

Main Methods:

  • Assessed ADP-stimulated and non-stimulated P-selectin expression in platelets from pregnant women, patients with pituitary tumors (normo- and hyperprolactinemic), and controls.

Related Experiment Videos

  • Studied platelet aggregation induced by human PRL in vitro.
  • Correlated PRL levels with platelet activation markers.

    • Main Results:

    • A significant positive correlation was observed between PRL levels and ADP-stimulated platelet activation in pregnant women and patients with pituitary tumors.
    • Hyperprolactinemic individuals (pregnant or with pituitary tumors) exhibited significantly higher ADP-stimulated platelet activation compared to controls.
    • In vitro studies confirmed that human PRL increases platelet stimulation and aggregation.

    Conclusions:

    • Hyperprolactinemia directly contributes to increased platelet aggregation via ADP stimulation, both in vitro and in vivo.
    • Prolactin (PRL) may act as a physiological cofactor influencing coagulation balance during pregnancy and puerperium.
    • These findings suggest a potential mechanism linking hyperprolactinemia to the elevated VTE risk observed in pregnant women, warranting further investigation.